SpyGlass Pharma has released positive data from 2 trials of its lead candidate, the Bimatoprost Drug Pad-IOL System (BIM-IOL ...
Paul Badawi, Founder and CEO of Sight Sciences and Leon Herndon, MD, Duke University Eye Center, Durham, NC, commented on the ...
First-in-Human(FIH)Trialat36Months:37% reduction in mean intraocular pressure (IOP) in evaluable patients across all dose ...
We are proud to continuously support the study of interventional glaucoma treatment, especially in highlighting critical groups of patients that may benefit from active surgical interventions. These ...
(11/4/25) The energy price index fell 3.7% in October, driven by a 5.1% decline in crude oil prices, partially offset by a 7.5% rise in U.S. natural gas prices. The non-energy price index changed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback